173 related articles for article (PubMed ID: 9305368)
1. Absence of anti-P/Q calcium channel antibody in the sera of patients with anti-Yo antibody-positive paraneoplastic cerebellar degeneration.
Tanaka K; Motomura M; Nakao Y; Tanaka M; Tsuji S
Neurology; 1997 Sep; 49(3):895-6. PubMed ID: 9305368
[No Abstract] [Full Text] [Related]
2. Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome.
Mason WP; Graus F; Lang B; Honnorat J; Delattre JY; Valldeoriola F; Antoine JC; Rosenblum MK; Rosenfeld MR; Newsom-Davis J; Posner JB; Dalmau J
Brain; 1997 Aug; 120 ( Pt 8)():1279-300. PubMed ID: 9278623
[TBL] [Abstract][Full Text] [Related]
3. Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes.
Lennon VA; Kryzer TJ; Griesmann GE; O'Suilleabhain PE; Windebank AJ; Woppmann A; Miljanich GP; Lambert EH
N Engl J Med; 1995 Jun; 332(22):1467-74. PubMed ID: 7739683
[TBL] [Abstract][Full Text] [Related]
4. SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome.
Sabater L; Titulaer M; Saiz A; Verschuuren J; Güre AO; Graus F
Neurology; 2008 Mar; 70(12):924-8. PubMed ID: 18032743
[TBL] [Abstract][Full Text] [Related]
5. Favourable prognosis in Lambert-Eaton myasthenic syndrome and small-cell lung carcinoma.
Maddison P; Newsom-Davis J; Mills KR; Souhami RL
Lancet; 1999 Jan; 353(9147):117-8. PubMed ID: 10023900
[No Abstract] [Full Text] [Related]
6. Autoantibody screening in subacute cerebellar ataxia.
Trivedi R; Mundanthanam G; Amyes E; Lang B; Vincent A
Lancet; 2000 Aug; 356(9229):565-6. PubMed ID: 10950237
[TBL] [Abstract][Full Text] [Related]
7. [Paraneoplastic neurologic syndromes. 2. Lambert-Eaton myasthenic syndrome. 2) Anti-calcium channel antibody and clinical features].
Nakao Y; Motomura M; Suenaga A; Nakamura T; Yoshimura T; Tsujihata M; Ito M; Kono S; Eguchi K
Nihon Naika Gakkai Zasshi; 1998 Apr; 87(4):685-90. PubMed ID: 9627478
[No Abstract] [Full Text] [Related]
8. P/Q-type voltage-gated calcium channel antibodies in paraneoplastic disorders of the central nervous system.
Voltz R; Carpentier AF; Rosenfeld MR; Posner JB; Dalmau J
Muscle Nerve; 1999 Jan; 22(1):119-22. PubMed ID: 9883867
[TBL] [Abstract][Full Text] [Related]
9. Calcium channel autoantibody and non-small-cell lung cancer in patients with Lambert-Eaton syndrome.
Sher E; Comola M; Nemni R; Canal N; Clementi F
Lancet; 1990 Feb; 335(8686):413. PubMed ID: 1968140
[No Abstract] [Full Text] [Related]
10. Antibodies to recombinant synaptotagmin and calcium channel subtypes in Lambert-Eaton myasthenic syndrome.
Takamori M; Takahashi M; Yasukawa Y; Iwasa K; Nemoto Y; Suenaga A; Nagataki S; Nakamura T
J Neurol Sci; 1995 Nov; 133(1-2):95-101. PubMed ID: 8583238
[TBL] [Abstract][Full Text] [Related]
11. [Report of a case of small cell lung cancer associated with Lambert-Eaton myasthenic syndrome and subacute cerebellar degeneration--with a review of the Japanese literature].
Ohkubo K; Ohishi K; Motomura M; Sakai K; Tsujihata M; Nagataki S
No To Shinkei; 1994 Mar; 46(3):285-9. PubMed ID: 8192944
[TBL] [Abstract][Full Text] [Related]
12. Do calcium channel autoantibodies cause cerebellar ataxia with Lambert-Eaton syndrome?
Fletcher CF; Lennon VA
Ann Neurol; 2003 Jan; 53(1):5-7. PubMed ID: 12509841
[No Abstract] [Full Text] [Related]
13. SOX1 autoantibodies: tumor markers in LEMS patients?
Lang B; Evoli A
Neurology; 2008 Mar; 70(12):906-7. PubMed ID: 18347313
[No Abstract] [Full Text] [Related]
14. Association of antineural autoantibodies in a patient with paraneoplastic cerebellar syndrome and small cell lung carcinoma.
Honnorat J; Aguera M; Guillon B; De Ferron E; Antoine JC; Dalmau J
J Neurol Neurosurg Psychiatry; 1997 Apr; 62(4):425-6. PubMed ID: 9120474
[No Abstract] [Full Text] [Related]
15. Calcium channel autoantibodies in myasthenic syndrome and small cell lung cancer.
Pelucchi A; Ciceri E; Clementi F; Marazzini L; Foresi A; Sher E
Am Rev Respir Dis; 1993 May; 147(5):1229-32. PubMed ID: 8387255
[TBL] [Abstract][Full Text] [Related]
16. The role of autoantibodies in Lambert-Eaton myasthenic syndrome.
Lang B; Waterman S; Pinto A; Jones D; Moss F; Boot J; Brust P; Williams M; Stauderman K; Harpold M; Motomura M; Moll JW; Vincent A; Newsom-Davis J
Ann N Y Acad Sci; 1998 May; 841():596-605. PubMed ID: 9668304
[No Abstract] [Full Text] [Related]
17. Humoral immunity against glutamic acid decarboxylase and tyrosine phosphatase IA-2 in Lambert-Eaton myasthenic syndrome.
Hermitte L; Martin-Moutot N; Boucraut J; Barone R; Atlan-Gepner C; Seagar M; Pouget J; Kleisbauer JP; Couraud F; Vialettes B
J Clin Immunol; 2000 Jul; 20(4):287-93. PubMed ID: 10939716
[TBL] [Abstract][Full Text] [Related]
18. Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 1. Mouse strains bearing different MHC molecules produce antibodies on immunization with recombinant Yo protein, but do not cause Purkinje cell loss.
Tanaka M; Tanaka K; Onodera O; Tsuji S
Clin Neurol Neurosurg; 1995 Feb; 97(1):95-100. PubMed ID: 7788981
[TBL] [Abstract][Full Text] [Related]
19. Lambert-Eaton myasthenic syndrome. Antigenicity of recombinant human P/Q-type calcium channel alpha 1 subunit putative ion pore region (domain IV, S5-S6).
Black JL; Griesmann GE; Erickson J; Kryzer TJ; Lamke GT; Lennon VA
Ann N Y Acad Sci; 1998 May; 841():691-5. PubMed ID: 9668316
[No Abstract] [Full Text] [Related]
20. [Paraneoplastic cerebellar degeneration--characterization of anti-Yo antibody and underlying cancer].
Tanaka K; Tanaka M; Onodera O; Tsuji S
Rinsho Shinkeigaku; 1995 Jul; 35(7):770-4. PubMed ID: 8777801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
